Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

What's New with COVID in 2024?

Michigan Medicine

L. Washer

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

IDWeek 2024 Insights: Management of Substance Use Disorders in HIV

IDWeek 2024 Insights

H. Hurley

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

Update on Adult Immunizations (July 2024): Part 2

Barbara Yawn

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello